By Monica Heger
The goal is to find personalized biomarkers in the immune system that will lead to better and earlier diagnostics.
T-cell receptor sequencing is "a long way from being used clinically," said Robert Holt, head of sequencing at the BC Cancer Agency's Genome Sciences Center and senior author of a recent paper on the subject.
The company has opened a San Francisco office to provide bioinformatics development and analysis services to life science customers in the area.
The company said that it will eventually provide diagnostic and prognostic tests, as well as monitoring, for infection, auto-immune diseases, and cancer.
Leveraging the "absurd revolution in DNA sequencing costs" over the past decade, the San Francisco-based firm is developing an assay for interrogation of the immune repertoire.
Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.
Researchers have 3D-printed plastic bunnies that encase the information needed to make more such bunnies in DNA, according to Discover magazine.
Dan Rather, the former CBS Evening News anchor and executive producer of a new documentary, writes at the Guardian that everyone needs to know about CRISPR.
In PNAS this week: analysis of FOXA1 upregulation in ER-positive breast cancer, gene editing to correct recessive dystrophic epidermolysis bullosa, and more.